3 Stocks To Transform Your Portfolio: HSBC Holdings plc, GlaxoSmithKline plc And Banco Santander SA

HSBC Holdings plc (LON: HSBA), GlaxoSmithKline plc (LON: GSK) and Banco Santander SA (LON: BNC) could make all the difference to your finances

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Cash

Sometimes, it’s difficult to find high-quality companies trading at attractive valuations. Indeed, during bull markets it can be especially tough, as valuations become rather excessive.

However, with the FTSE 100 still being at roughly the same price level as it was fourteen years ago, there seems to be a number of high-quality companies trading at low prices. Here are three examples that could transform your portfolio returns over the medium term.

HSBC

With a large exposure to Asia, HSBC (LSE: HSBA) (NYSE: HSBC.US) seems to be well positioned to benefit from an economic tailwind. That’s because demand for new loans should increase as the Asian economy develops towards a more consumer-based model over the long run.

However, even in the short run, HSBC has huge potential. For example, it is expected to increase earnings per share (EPS) by 6% in the current year and by 7% next year. This rate of growth may not be quite as impressive as some of its UK-listed banking peers but, when you consider that HSBC has remained profitable throughout the credit crunch, steady, resilient earnings start to become much more attractive.

With shares in HSBC trading on a price to earnings (P/E) ratio of just 12.1, they seem to offer good value as well as upbeat growth prospects.

GlaxoSmithKline

Although sentiment surrounding GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) remains weak due to allegations of bribery, the long term still looks very bright for the pharmaceutical major. That’s because its pipeline of drugs is well diversified and has huge potential when it comes to gaining approval for key, blockbuster drugs.

Despite these strong prospects, shares in GlaxoSmithKline still offer great value right now. For example, they trade on a P/E of 15.2. While this is above the FTSE 100’s rating of 13.6, it’s well below many of its pharmaceutical peers, where P/Es of 20+ are commonplace.

Allied to great value is a top notch yield of 5.6%, which makes GlaxoSmithKline a strong income as well as value (and growth) play.

Santander

When it comes to growth potential, Santander (LSE: BNC) has it in bucket loads. For example, earnings are forecast to increase by 23% in the current year and by a further 22% next year. This is a stunning rate of growth and means that, with shares in Santander trading on a P/E ratio of 15.8, the bank offers growth at a reasonable price via a price to earnings growth (PEG) ratio of 0.6.

Furthermore, Santander yields 6.5% and, as of next year, dividends per share are expected to be covered by profit. This puts Santander on a much stronger financial footing moving forward and means that its shares could boost your portfolio returns.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of GlaxoSmithKline and HSBC Holdings. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Up 26%, can the BT share price really push higher still?

The BT share price has surged on several catalysts in 2024, but there’s evidence to suggest that the stock could…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

What are the best dividend shares to buy right now?

As shares in B&M European Value Retail have fallen, the dividend yield has reached a 10-year high. Should investors be…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

My favourite FTSE 100 passive income stock that keeps the Christmas coffers full

The holiday season is expensive and can leave many consumers struggling to make ends meet. Here’s how I use a…

Read more »

Investing Articles

The latest growth forecasts suggest the Glencore share price will hit 555p!

Harvey Jones has been disappointed by the performance of the Glencore share price since he bought the commodity stock last…

Read more »

Dividend Shares

A closer look at the 11% dividend yield forecast for Phoenix Group shares

Phoenix Group shares have one of the highest dividend yields in the FTSE 100 index today. Could this be a…

Read more »

Investing Articles

If I’d put £25,000 into the FTSE 350 at the start of 2024, here’s how much I’d have today!

Many FTSE shares have rebounded this year as interest rates look set to keep heading lower and market appetite for…

Read more »

Investing Articles

Up 40%, but experts forecast the easyJet share price could soon hit 664p! Time to buy?

The easyJet share price has been flying lately and stock analysts are predicting more fun to come. But there's only…

Read more »

Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings
Investing Articles

Worried about tax raids? Here’s how I’m targeting a £44,526 passive income with shares

Investing in a Self-Invested Personal Pension (SIPP) or Individual Savings Account (ISA) can supercharge one's passive income, says Royston Wild.

Read more »